Table 2:
Frequency with which pre-treatment CT reports for patients with suspected advanced ovarian cancer mentioned the presence versus absence of disease involving 45 clinically relevant anatomic sites, stratified by type of CT report generated.
| Anatomic Site | Simple Structured Report (n=128) | Synoptic Report (n=77) | Adjusted pa |
|---|---|---|---|
| Hepatobiliary | |||
| Parenchymal metastasis(es) | 114/128 (89) | 77 (100) | .001 |
| Capsular implant | |||
| Subdiaphragmatic | 32 (25) | 77 (100) | <.001 |
| Perihepatic | 36 (28) | 77 (100) | <.001 |
| Hepatorenal recess | 19 (15) | 77 (100) | <.001 |
| Fissure for ligamentum venosum | 14 (11) | 77 (100) | <.001 |
| Falciform ligament | 23 (18) | 77 (100) | <.001 |
| Porta hepatis | 15 (12) | 77 (100) | <.001 |
| Gallbladder fossa | 13 (10) | 77 (100) | <.001 |
| Spleen | |||
| Parenchymal metastasis(es) | 115 (90) | 77 (100) | <.001 |
| Capsular implant | |||
| Subdiaphragmatic | 15 (12) | 77 (100) | <.001 |
| Hilar | 18 (14) | 77 (100) | <.001 |
| Gastrosplenic ligament | 10/128 (8) | 77 (100) | <.001 |
| Splenocolic ligament | 11/128 (9) | 77 (100) | <.001 |
| Splenorenal ligament | 7/128 (5) | 77 (100) | <.001 |
| Abdominopelvic lymph nodes | |||
| Supradiaphragmatic | 89 (70) | 71 (92) | <.001 |
| Retrocrural | 31 (24) | 72 (94) | <.001 |
| Abdominal lymph nodes | |||
| Gastrohepatic | 70 (55) | 77 (100) | <.001 |
| Porta hepatis | 70 (55) | 77 (100) | <.001 |
| Portocaval | 74 (58) | 77 (100) | <.001 |
| Suprarenal retroperitoneal | 72 (56) | 77 (100) | <.001 |
| Infrarenal retroperitoneal | 80 (62) | 77 (100) | <.001 |
| Mesenteric | 72 (56) | 77 (100) | <.001 |
| Pelvic lymph nodes | |||
| Common iliac | 75 (59) | 76 (99) | <.001 |
| External iliac | 80 (63) | 77 (100) | <.001 |
| Internal iliac | 68 (53) | 76 (99) | <.001 |
| Obturator | 71 (55) | 76 (99) | <.001 |
| Mesorectal | 69 (54) | 76 (99) | <.001 |
| Superior rectal | 70 (55) | 75 (97) | <.001 |
| Inguinal | 73 (57) | 76 (99) | <.001 |
| Pelvic organs | |||
| Right adnexa | 117 (91) | 77 (100) | .008 |
| Left adnexa | 116 (91) | 77 (100) | .004 |
| Peritoneum, mesentery, and bowel | |||
| Implants | |||
| Omental | 91 (71) | 77 (100) | <.001 |
| Right paracolic gutter | 19 (15) | 77 (100) | <.001 |
| Left paracolic gutter | 18 (14) | 77 (100) | <.001 |
| Lesser sac | 26 (20) | 77 (100) | <.001 |
| Gastrocolic ligament | 21 (16) | 77 (100) | <.001 |
| Small bowel mesentery | 6 (5) | 60 (78) | <.001 |
| Small bowel serosa | 43 (34) | 77 (100) | <.001 |
| Colonic wall | 32 (25) | 77 (100) | <.001 |
| Gastric wall | 12 (9) | 77 (100) | <.001 |
| Cul-de-sac | 49 (38) | 77 (100) | <.001 |
| Ascites | 114 (89) | 77 (100) | .001 |
| Abdominal wall metastasis(es) | 16 (13) | 77 (100) | <.001 |
| Other | |||
| Pleural effusion(s) | 62 (48) | 77 (100) | <.001 |
| Pleural nodule(s) | 8 (6) | 77 (100) | <.001 |
Note—Exept where otherwise indicated, data are number with percentage in parentheses.
a
Fisher’s exact test with adjustment of p values for multiple comparisons based on false-discovery rate.